• UiPath shares rose 6.62% as investor confidence grew around the company’s AI automation advances.
  • UiPath’s Screen Agent, powered by Claude Opus 4.5, claimed the top spot on the OSWorld‑Verified benchmark.
  • Barclays set a new price target of $18, signaling analyst optimism in the software sector.

What happened

UiPath Inc. saw its stock price climb 6.62% after market reaction to recent product and benchmark news. The immediate catalyst cited by traders and analysts was the performance of UiPath’s Screen Agent, which—according to reports—uses Claude Opus 4.5 and secured the top position on the OSWorld‑Verified benchmark. Shortly afterward, Barclays published an updated note setting a new $18 price target for UiPath, reinforcing upbeat sentiment among institutional investors.

Why it matters

The benchmark win and the Barclays target together are a form of social proof: an independent performance ranking plus a respected bank’s target can validate the company’s positioning in AI automation. For investors and enterprise customers, that combination signals that UiPath’s automation tooling may be becoming more competitive in practical, measurable ways.

What Screen Agent’s win signifies

OSWorld‑Verified rankings are used by buyers and developers to compare capabilities across automation tools. Screen Agent’s top ranking—attributed to Claude Opus 4.5 integration—suggests improvements in task accuracy, reliability, or speed, which can directly affect adoption in real‑world automation projects. Strong benchmark results can influence procurement decisions at large companies and encourage partners to deepen integrations.

Market reaction and outlook

The 6.62% intraday gain reflects short‑term optimism, but market moves of this size also highlight two important dynamics:

  • FOMO: Some investors rush to buy into momentum trades after positive news, which can amplify price moves.
  • Risk: Analyst targets and benchmark wins don’t guarantee sustained revenue growth; competition and macroeconomic conditions still matter.

Analyst and industry context

Barclays’ new $18 target serves as a signal that at least one major analyst sees improved prospects for UiPath within the software sector. However, targets differ among firms and depend on assumptions about customer adoption rates, pricing power, and cost control. Industry watchers will be looking for follow‑through in UiPath’s next earnings report or customer wins to see whether the momentum holds.

Bottom line

UiPath’s recent milestone — a top OSWorld‑Verified ranking for Screen Agent powered by Claude Opus 4.5 plus a raised analyst target from Barclays — has created a wave of investor interest and a 6.62% stock uptick. That mix of technical validation and analyst optimism raises the company’s profile, but investors should weigh the upside against execution risks and broader market conditions before assuming a sustained rally.

Image Referance: https://www.timothysykes.com/news/uipath-inc-path-news-2026_02_06/